Introduction

In an era of unprecedented opportunity for growth-stage investors, Tech Meets Capital: Unlocking Scale with Growth Stage Investors offers an in-depth analysis of the evolving digital health investment landscape. Leveraging Galen Growth’s proprietary data, this report reveals how Series B and C funding rebounded to 29% of total investments in H1 2024 after a five-year low. It uncovers key sectors like Health Management Solutions and Medical Diagnostics driving investor focus, highlights regional disparities in funding, and examines the untapped potential of over 1,900 ventures. This resource empowers stakeholders to identify trends, capitalize on growth-stage opportunities, and drive the next wave of digital health innovation.

Key insights from the report

• Growth-Stage Resurgence: Series B and C funding accounted for 29% of investments in H1 2024, marking a significant recovery after a five-year low in 2023.
• Funding Challenges: Only 19% of Series A and B ventures secured funding in the past year, leaving 81% actively seeking opportunities.
• Sector Focus: Health Management Solutions and Medical Diagnostics led the way, representing 41% of investments by the top 10 growth-stage investors over the last 12 months.
• Regional Disparities: North America captured 84% of growth-stage investments over the past year, dwarfing Europe’s 6%, highlighting the need for regional strategy adjustments.
• Future Opportunities: Over 1,900 Series A and B ventures without recent funding provide a robust pipeline for investors in 2025, with 25% concentrated in Medical Diagnostics.

Why it matters

The digital health ecosystem is at a crossroads, with growth-stage ventures poised to unlock transformative opportunities. Understanding where capital is flowing and which sectors are thriving is critical for investors, startups, and industry leaders. Tech Meets Capital provides the actionable insights needed to navigate the complexities of the funding landscape, seize opportunities in underfunded areas, and align with trends like AI-driven innovation. For stakeholders aiming to drive growth and scale, this report is an essential roadmap.

This report is powered by HealthTech Alpha, the premier digital health intelligence platform delivering unparalleled data and insights into the evolving healthcare technology landscape. By leveraging its extensive database of over 14,000 ventures and cutting-edge analytics, HealthTech Alpha provides a data-driven foundation to analyze the critical trends and innovations shaping the future of medtech.

Designed to empower stakeholders—including investors, pharmaceutical leaders, and medical device manufacturers—HealthTech Alpha offers actionable intelligence to navigate the complexities of digital transformation in healthcare. This collaboration brings readers a comprehensive view of the intersection between digital health and medtech, equipping them with the insights needed to identify opportunities, assess market dynamics, and make strategic decisions in this rapidly advancing industry.

Also read our recent update on Europe Digital Health Funding in Q3 2024, which soared by 19% as AI ventures thrived and partnerships surged.